Correlation Between BioLineRx and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both BioLineRx and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLineRx and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLineRx and Purple Biotech, you can compare the effects of market volatilities on BioLineRx and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLineRx with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLineRx and Purple Biotech.
Diversification Opportunities for BioLineRx and Purple Biotech
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between BioLineRx and Purple is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding BioLineRx and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and BioLineRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLineRx are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of BioLineRx i.e., BioLineRx and Purple Biotech go up and down completely randomly.
Pair Corralation between BioLineRx and Purple Biotech
Given the investment horizon of 90 days BioLineRx is expected to under-perform the Purple Biotech. In addition to that, BioLineRx is 2.73 times more volatile than Purple Biotech. It trades about -0.18 of its total potential returns per unit of risk. Purple Biotech is currently generating about -0.04 per unit of volatility. If you would invest 382.00 in Purple Biotech on October 25, 2024 and sell it today you would lose (22.00) from holding Purple Biotech or give up 5.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
BioLineRx vs. Purple Biotech
Performance |
| Timeline |
| BioLineRx |
| Purple Biotech |
BioLineRx and Purple Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioLineRx and Purple Biotech
The main advantage of trading using opposite BioLineRx and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLineRx position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.| BioLineRx vs. Ardelyx | BioLineRx vs. Lexicon Pharmaceuticals | BioLineRx vs. Seres Therapeutics | BioLineRx vs. Immunitybio |
| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |